These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 7745016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
    Yballe CM, Vu TH, Hoffman AR.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
    [Abstract] [Full Text] [Related]

  • 3. Maintenance of imprinting of the insulin-like growth factor II gene (IGF2) and the small nuclear ribonucleoprotein polypeptide N gene (SNRPN) in the human uterus and leiomyoma.
    Hashimoto K, Azuma C, Kamiura S, Koyama M, Nobunaga T, Tokugawa Y, Kimura T, Kubota Y, Sawai K, Saji F.
    Gynecol Obstet Invest; 1996 Apr; 41(1):50-4. PubMed ID: 8821886
    [Abstract] [Full Text] [Related]

  • 4. Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas.
    Rainho CA, Pontes A, Rogatto SR.
    Gynecol Oncol; 1999 Sep; 74(3):375-80. PubMed ID: 10479496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH, Hoffman A.
    J Biol Chem; 1996 Apr 12; 271(15):9014-23. PubMed ID: 8621549
    [Abstract] [Full Text] [Related]

  • 8. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM.
    Cancer Res; 1993 Oct 15; 53(20):4781-3. PubMed ID: 8402661
    [Abstract] [Full Text] [Related]

  • 9. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH, Chuyen NV, Li T, Hoffman AR.
    Cancer Res; 2003 Apr 15; 63(8):1900-5. PubMed ID: 12702581
    [Abstract] [Full Text] [Related]

  • 10. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
    Wada M, Seeger RC, Mizoguchi H, Koeffler HP.
    Cancer Res; 1995 Aug 01; 55(15):3386-8. PubMed ID: 7614476
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH, Duan JX, Vu TH, Hoffman AR.
    J Biol Chem; 1996 Nov 01; 271(44):27863-70. PubMed ID: 8910385
    [Abstract] [Full Text] [Related]

  • 12. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekström TJ.
    Oncogene; 1995 Jul 20; 11(2):221-9. PubMed ID: 7624139
    [Abstract] [Full Text] [Related]

  • 13. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ, Grundy P, Polychronakos C.
    Oncogene; 1997 Mar 06; 14(9):1041-6. PubMed ID: 9070652
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor gene expression in human smooth muscle tumors.
    Gloudemans T, Prinsen I, Van Unnik JA, Lips CJ, Den Otter W, Sussenbach JS.
    Cancer Res; 1990 Oct 15; 50(20):6689-95. PubMed ID: 2208134
    [Abstract] [Full Text] [Related]

  • 15. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma.
    Lawson EA, Zhang X, Crocker JT, Wang WL, Klibanski A.
    J Clin Endocrinol Metab; 2009 Jul 15; 94(7):2226-31. PubMed ID: 19383775
    [Abstract] [Full Text] [Related]

  • 16. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
    Nonomura N, Miki T, Nishimura K, Kanno N, Kojima Y, Okuyama A.
    J Urol; 1997 May 15; 157(5):1977-9. PubMed ID: 9112575
    [Abstract] [Full Text] [Related]

  • 17. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
    Takeda S, Kondo M, Kumada T, Koshikawa T, Ueda R, Nishio M, Osada H, Suzuki H, Nagatake M, Washimi O, Takagi K, Takahashi T, Nakao A, Takahashi T.
    Oncogene; 1996 Apr 04; 12(7):1589-92. PubMed ID: 8622877
    [Abstract] [Full Text] [Related]

  • 18. Loss of imprinting of IGF2 in Ewing's sarcoma.
    Zhan S, Shapiro DN, Helman LJ.
    Oncogene; 1995 Dec 21; 11(12):2503-7. PubMed ID: 8545106
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
    Yang Y, Hu JF, Ulaner GA, Li T, Yao X, Vu TH, Hoffman AR.
    J Cell Biochem; 2003 Dec 01; 90(5):1038-55. PubMed ID: 14624463
    [Abstract] [Full Text] [Related]

  • 20. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma.
    Albrecht S, Waha A, Koch A, Kraus JA, Goodyer CG, Pietsch T.
    J Neuropathol Exp Neurol; 1996 Dec 01; 55(12):1270-6. PubMed ID: 8957451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.